Literature DB >> 1313365

Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.

J L Fendrick1, W J Iglewski, J M Moehring, T J Moehring.   

Abstract

Anti-[ADP-ribosylated elongation factor 2 (EF-2)] antiserum has been used to immunoprecipitate the modified form of EF-2 from polyoma-virus-transformed baby hamster kidney (pyBHK) cells [Fendrick, J. L. & Iglewski, W. J. (1989) Proc. Natl Acad. Sci. USA 86, 554-557]. This antiserum also immunoprecipitates a 32P-labelled protein of similar size to EF-2 from a variety of primary and continuous cell lines derived from many species of animals. One of these cell lines, chinese hamster ovary CHO-K1 cells was further characterized. The time course of labelling of ADP-ribosylated EF-2 with [32P]orthophosphate was similar in pyBHK cells and in CHO-K1 cells. The kinetics of labelling were more rapid for cells cultured in 2% serum than 10% serum, with incorporation of 32P reaching a maximum at 6 h and 10 h, respectively. EF-2 mutants of pyBHK and CHO-K1 cells resistant to diphtheria-toxin-catalyzed ADP-ribosylation of EF-2 remain sensitive to cellular ADP-ribosylation of EF-2. The 32P-labelled moiety of ADP-ribosylated EF-2 was digested by snake venom phosphodiesterase and the product was identified as AMP. The same 32P-labelled tryptic peptide was modified by toxin in wild-type EF-2 and by the cellular transferase in mutant EF-2. When purified EF-2 from pyBHK cells was incubated with [carbonyl-14C]nicotinamide and diphtheria toxin fragment A, under conditions for reversal of the ADP-ribosylation reaction, [14C]NAD was generated. The results suggest that cellular ADP-ribosylated EF-2 exists in a variety of cell types, and the ribosylated product is identical to that produced by toxin ADP-ribosylation of EF-2, except in diphthamide mutant cells. Studies with the mutant cell lines indicate that the toxin and the cellular transferase, however, recognize different determinants at the ADP-ribose acceptor site in EF-2. The cellular transferase does not require the diphthamide modification of the histidine ring in the amino acid sequence of EF-2 for the transfer of ADP-ribose to the ring. Therefore, we would expect the cellular transferase active site to be similar to, but not identical to, the critical amino acids demonstrated in the active site of diphtheria toxin and Pseudomonas exotoxin A.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313365     DOI: 10.1111/j.1432-1033.1992.tb16748.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle.

Authors:  A Zolkiewska; M S Nightingale; J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  Combining affinity purification by ADP-ribose-binding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteome.

Authors:  Nadia Dani; Annalisa Stilla; Adriano Marchegiani; Antonio Tamburro; Susanne Till; Andreas G Ladurner; Daniela Corda; Maria Di Girolamo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

3.  Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1.

Authors:  U Brinkmann; E Brinkmann; M Gallo; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 4.  Cellular ADP-ribosylation of elongation factor 2.

Authors:  W J Iglewski
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

Review 5.  Vertebrate mono-ADP-ribosyltransferases.

Authors:  A Zolkiewska; I J Okazaki; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

6.  Molecular cloning of the black tiger shrimp (Penaeus monodon) elongation factor 2 (EF-2): sequence analysis and its expression on the ovarian maturation stage.

Authors:  Lihua Qiu; Shigui Jiang; Falin Zhou; Dianchang Zhang; Jianhua Huang; Yihui Guo
Journal:  Mol Biol Rep       Date:  2007-07-13       Impact factor: 2.316

7.  Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus.

Authors:  A AEvarsson; E Brazhnikov; M Garber; J Zheltonosova; Y Chirgadze; S al-Karadaghi; L A Svensson; A Liljas
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

Review 8.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

Review 9.  The biosynthesis and biological function of diphthamide.

Authors:  Xiaoyang Su; Zhewang Lin; Hening Lin
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-08-23       Impact factor: 8.697

10.  Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins.

Authors:  U Brinkmann; E Brinkmann; I Pastan
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.376

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.